Extending facility accreditation to the evaluation of care: The Australian experience
β Scribed by Brian T. Collopy
- Publisher
- John Wiley and Sons
- Year
- 1995
- Tongue
- English
- Weight
- 388 KB
- Volume
- 10
- Category
- Article
- ISSN
- 0749-6753
No coin nor oath required. For personal study only.
β¦ Synopsis
The Australian Council on Healthcare Standards (ACHS) has introduced clinical performance measures -clinical indicators -into the accreditation process. The indicators are developed with the assistance of the various medical colleges (professional associations of specialists). Sixteen such bodies are now in the program, with 150 draft indicators covering 90 areas of hospital practice. The development of a set of indicators passes through a number of stages to ensure their validity, and a process is in place to assess their reliability, reproducibility and responsiveness. The qualitative information available indicates a willingness on the part of health care facilities to address the indicators, and alter the process of care. It is anticipated that the quantitative information being collected in aggregate form w i l l subsequently demonstrate an improvement in the outcome of care. Hospital specific information currently remains confidential to the ACHS and the particular health care facility. The public release of such information and the value of doing so remains undetermined.
π SIMILAR VOLUMES
Since 1979, the Portuguese health care system has been based on a National Health Service structure that is expected to promote equity, efficiency, quality, accountability and the devolution of power. In this article, we analyse the content and impact of policies designed to reform the system betwee
## Abstract __Background__: IQWiG commissioned an international panel of experts to develop methods for the assessment of the relation of benefits to costs in the German statutory healthβcare system. __Proposed methods__: The panel recommended that IQWiG inform German decision makers of the net co
One of the main issues to be considered in conducting clinical trials concerns the presence of missing data. This aspect is particularly relevant in oncology longitudinal studies, characterized by a long follow-up, and especially in quality of life studies where there is still little knowledge about